TROPANE DERIVATIVES HAVING DOPAMINE REUPTAKE INHIBITOR ACTIVITY FOR THE TREATMENT OF ISCHEMIC DISEASES

Details for Australian Patent Application No. 2002365288 (hide)

Owner NEUROSEARCH A/S

Inventors RONN, Lars, Christian, B.; SCHEELKRUGER, Jorgen

Pub. Number AU-A-2002365288

PCT Number PCT/DK02/00796

PCT Pub. Number WO2003/045388

Priority PA 2001 01781 30.11.01 DK

Filing date 28 November 2002

Wipo publication date 10 June 2003

International Classifications

A61K 031/46 - 8-Azabicyclo [3.2.1] octane

A61P 009/10 Drugs for disorders of the cardiovascular system

A61P 025/00 Drugs for disorders of the nervous system

C07D 451/02 Heterocyclic compounds containing condensed hetero ring systems

C07D 471/18 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): PA 2001 01781 30.11.01 DK

21 August 2003 Application Open to Public Inspection

  Published as AU-A-2002365288

19 August 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002365289-USE OF SELECTIVE POTASSIUM CHANNEL OPENERS

2002365287-PORTABLE DELIVERY DEVICE, PRESSURISED BY A PUMPED LIQUID, AND CARTRIDGE THEREFORE